D. G. Brown, T. L. May-dracka, and M. M. Gagnon, Trends and exceptions of physical 357 properties on antibacterial activity for Gram-positive and Gram-negative pathogens, J, vol.358

, Med Chem, vol.57, pp.10144-61, 2014.

D. J. Payne, M. N. Gwynn, and D. J. Holmes, Drugs for bad bugs: confronting the challenges of 360 antibacterial discovery, Nat Rev Drug Discov, vol.6, pp.29-40, 2007.

R. R. Watkins and R. A. Bonomo, Overview: Global and local impact of antibiotic resistance

, Antibiot Resist Chall Oppor, vol.30, pp.313-335, 2016.

R. Laxminarayan, P. Matsoso, and S. Pant, Access to effective antimicrobials: a worldwide 364 challenge, The Lancet, vol.387, pp.168-75, 2016.

H. W. Boucher, G. H. Talbot, and D. K. Benjamin, 10 x '20 Progress--development of new 366 drugs active against gram-negative bacilli: an update from the, Infectious Diseases, vol.367

A. Society-of, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.56, pp.1685-94, 2013.

M. G. Page and K. Bush, Discovery and development of new antibacterial agents targeting Gram-369 negative bacteria in the era of pandrug resistance: is the future promising?, Curr Opin 370 Pharmacol, vol.18, pp.91-98, 2014.

H. Nikaido, Molecular basis of bacterial outer membrane permeability revisited

, Mol Biol Rev, vol.67, pp.593-656, 2003.

J. Pagès, C. E. James, and M. Winterhalter, The porin and the permeating antibiotic: a selective 374 diffusion barrier in Gram-negative bacteria, Nat Rev Microbiol, vol.6, pp.893-903, 2008.

J. Blair, M. A. Webber, and A. J. Baylay, Molecular mechanisms of antibiotic resistance

, Nat Rev Microbiol, vol.13, pp.42-51, 2015.

M. Masi, M. Réfrégiers, and K. M. Pos, Prevention of drug access to bacterial targets: permeability barriers and active 380 efflux. -Semantic Scholar, Nat Microbiol, vol.2, pp.593-656, 1994.

X. Li, P. Plésiat, and H. Nikaido, The challenge of efflux-mediated antibiotic resistance in 382

, Gram-negative bacteria, Clin Microbiol Rev, vol.28, pp.337-418, 2015.

A. Davin-regli, J. Bolla, and C. E. James, Membrane permeability and regulation of 384 drug 'influx and efflux' in Enterobacterial pathogens, Curr Drug Targets, vol.9, pp.750-385, 2008.

H. I. Zgurskaya, C. A. Löpez, and S. Gnanakaran, Permeability barrier of Gram-negative cell 387 envelopes and approaches to bypass it, ACS Infect Dis, vol.1, pp.512-534, 2015.

G. Krishnamoorthy, I. V. Leus, and J. W. Weeks, Synergy between active efflux and outer 389 membrane diffusion defines rules of antibiotic permeation into Gram-negative bacteria, 390 mBio, vol.8, pp.1172-1189, 2017.

J. Bolla, S. Alibert-franco, and J. Handzlik, Strategies for bypassing the membrane 392 barrier in multidrug resistant Gram-negative bacteria, FEBS Lett, vol.585, pp.1682-1690, 2011.

R. A. Stavenger, M. Winterhalter, and . Translocation-project, How to get good drugs into 394 bad bugs, Sci Transl Med, vol.6, pp.228-235, 2014.

J. Blair and L. Piddock, How to measure export via bacterial multidrug resistance efflux 396 pumps, mBio, 2016.

, Data normality was checked by the Shapiro-Wilk test and 521 homogeneity of variances was checked by the Fligner-Killeen test